Promising clinical studies surrounding this compound, specifically the 120mg formulation branded as ZPHC, suggest a considerable benefit on physique decrease and related chronic factors. Researchers believe that this dual agonist , affecting both GLP-1 and GIP receptors , could provide a substantial advance in the treatment of overweight and assoc